Biotech / MedTech

MIMS Group is expanding MIMS Pulse and eMIMS Plus across markets while growing its medical communications and AI-enabled content capabilities.

Alibaba DAMO Academy has published research on EAGLE for esophageal cancer screening and RADAR for broad abdominal CT interpretation. Both remain research systems rather than approved clinical products.

GSK agreed to acquire global rights to a Chimagen multiple myeloma program in a deal with an undisclosed upfront fee and contingent payments totaling up to $750 million.

Australia’s VVMF has secured a TGA manufacturing license for its Westmead facility to produce specified viral vectors under GMP standards.

Merck, a global science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region.

Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.

Singapore-based investor AngelCentral announced Wednesday its first successful BioTech syndicate by its members to invest in RyboDyn Inc., a US biotechnology company pioneering the development of immunotherapies targeting the dark genome.

ChemT Biotechnology, an AI-driven biotechnology company based on Singapore, has closed a $4 million seed round led by Wavemaker Ventures and co-investment partner SEEDS, an arm of SG Growth Capital, with support from Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.

Melazyme, a precision fermentation startup focused on functional biomolecules, has raised $2 million in a seed funding round led by SeaX Ventures, with participation from Stellaris Venture Partners and Plug and Play Ventures.

Virdalis, a Singapore-based biotechnology company developing protein from Wolffia globosa—commonly known as duckweed—has secured US$700,000 in pre-seed funding led by Wavemaker Impact.